This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This COL4A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 156-186 amino acids from the N-terminal region of human COL4A2.
COL4A2
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
For FACS starting dilution is: 1:10~50
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
COL4a2 (COL4A2)
(Collagen, Type IV, alpha 2 (COL4A2))
col4a2-a antikoerper, zCanstatin antikoerper, ICH antikoerper, POREN2 antikoerper, Col4a-2 antikoerper, collagen, type IV, alpha 2 L homeolog antikoerper, collagen type IV alpha 2 chain antikoerper, collagen, type IV, alpha 2 antikoerper, col4a2.L antikoerper, COL4A2 antikoerper, col4a2 antikoerper, Col4a2 antikoerper
Hintergrund
This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter.